Constipation Therapeutic Pipeline Companies and Drugs Review H1 2015 Report at RnRMarketResearch.com
Dallas, TX (PRWEB) January 25, 2015 -- The report "Constipation – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Constipation. Constipation is a disorder in which a person has severe problems defecating. Constipation occurs primarily because of the lack of the bowel movement in the body. The Lack of bowel movement in the body results in hardening of stools, swollen abdomen or abdominal pain. The reasons for constipation to occur in a body are inadequate water intake, less proportion of fiber in diet, irregularities in the pattern of diet. Not maintaining proper health and inadequacy in exercise can also lead to the abnormality during defecation & would mostly end with painful symptoms. Complete Report is Available @ http://www.rnrmarketresearch.com/constipation-pipeline-review-h1-2015-market-report.html .
It also reviews key players involved in the therapeutic development for Constipation and special features on late-stage and discontinued projects. Companies discussed in this Constipation Pipeline Review H1 2015 report include AlbireoPharma, Astellas Pharma Inc., AstraZeneca PLC, Beech Tree Labs, Inc., Braintree Laboratories, Inc., Daiichi Sankyo Company, Limited, Dong-A Socio Group, Ironwood Pharmaceuticals, Inc., Kissei Pharmaceutical Co., Ltd., Lipid Pharmaceuticals ehf., Rhythm Pharmaceuticals, Sanwa Kagaku Kenkyusho Co., Ltd., Shire Plc, SK Biopharmaceuticals Co., Ltd., Sucampo Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., Synergy Pharmaceuticals, Inc., Teva Pharmaceutical Industries Limited.
The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=269557 . (This is a premium report priced at US$2000 for a single user License.)
Table of Contents
List of Tables
Number of Products under Development for Constipation, H1 2015
Number of Products under Development for Constipation - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Constipation - Pipeline by AlbireoPharma, H1 2015
Constipation - Pipeline by Astellas Pharma Inc., H1 2015
Constipation - Pipeline by AstraZeneca PLC, H1 2015
Constipation - Pipeline by Beech Tree Labs, Inc., H1 2015
Constipation - Pipeline by Braintree Laboratories, Inc., H1 2015
Constipation - Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Constipation - Pipeline by Dong-A Socio Group, H1 2015
Constipation - Pipeline by Ironwood Pharmaceuticals, Inc., H1 2015
Constipation - Pipeline by Kissei Pharmaceutical Co., Ltd., H1 2015
Constipation - Pipeline by Lipid Pharmaceuticals ehf., H1 2015
Constipation - Pipeline by Rhythm Pharmaceuticals, H1 2015
Constipation - Pipeline by Sanwa Kagaku Kenkyusho Co., Ltd., H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Constipation Therapeutics - Recent Pipeline Updates, H1 2015
Constipation - Dormant Projects, H1 2015
List of Figures
Number of Products under Development for Constipation, H1 2015
Number of Products under Development for Constipation - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015
Explore more reports on Infectious Diseases Therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/infectious-diseases-therapeutics .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, RnRMarketResearch, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article